and lungs. [14] [15] [16] [17] [18] [19] In particular, SVCT-2 is primarily responsible for the uptake of AsA from blood circulation into the adrenal cells. [14] [15] [16] [17] [18] [19] The adrenals have been shown to have the largest falls in the AsA levels in mice with a deficiency of SVCT-2, 20) and the influence of the depletion of tissue AsA on tissue catecholamines was found to be most prominent in the adrenals. 21, 22) In addition, it has recently been shown that overexpression of adrenal SVCT-2 mRNA in diabetic mice resulted in increased uptake of AsA. 23) Thus, it is most likely that the AsA transport mechanism plays an important role in the pathologic processes of the adrenals. 24) We became interested in the possibility that appropriate structural AsA analogs with specific transport characteristics, if possessing favorable in vivo distribution properties, might be used as tracer agents for the visualization of biochemical events associated with the action of AsA in the adrenal glands. Several AsA analogs labeled with 18 F, 131 I, 125 I, or 99m Tc were prepared and their potential imaging characteristics were evaluated in animals. [25] [26] [27] [28] [29] [30] [31] 6-Deoxy-6-iodo-L-ascorbic acid (6-IAsA) has been shown to be an effective inhibitor of AsA transport, with transport affinity similar to that of AsA, and that it is taken up into cells by a sodium-dependent AsA transporter. 32, 33) As part of our ascorbate studies, we recently reported the synthesis and preliminary biodistribution in normal mice of 6-deoxy-6-[ 131 I]iodo-L-ascorbic acid IAsA), which demonstrates high adrenal uptake in spite of considerable in vivo deiodination. 34) To further obtain information on the in vivo behavior of this radiotracer, this paper deals with biodistribution studies in normal rats by both the dissection procedure and whole-body autoradiography. In addition, we performed dis-tribution studies with this agent using 4-aminopyrazolo [3,4d] pyrimidine (4-APP)-induced hypolipidemic rats and also using nude mice with adrenal-derived tumors to assess the tumor uptake.
MATERIALS AND METHODS
Chemistry and Radiochemistry All reagent-grade chemicals were obtained from commercial suppliers and were used without further purification. IAsA, the chemical structure of which is shown in Fig. 1 , was prepared by a halogen exchange reaction between 6-bromo-6-deoxy-Lascorbic acid (6-BrAsA) and sodium [ 131 I]iodide and the product was purified by HPLC using a nitrogen-degassed solvent system (0.04 M Na 2 HPO 4 containing 0.1% triethylamine, pHϭ5.65), according to our previously reported procedure. 34) The isolated radiochemical yield was 54.7Ϯ14.2% with a radiochemical purity of 95% and the specific radioactivity of 17-75 GBq/mmol, as determined by radio-HPLC. The maximum amount of the precursor (6-BrAsA) in the 6-131 IAsA samples was estimated to be about 1 nmol.
Animals Animal care and all experimental procedures were carried out in accordance with Faculty Regulations on animal experiments of the Faculty of Pharmaceutical Sciences, Kyushu University. All the animals used in this study were given free access to food and water during the investigation.
Tissue Distribution Studies in Normal Rats Female Sprague-Dawley rats (9 to 11 weeks old, weighing ca. 190 g) were intravenously injected through the tail vein with a solution of 6-131 IAsA (4.87 kBq, 150-300 ml) in 0.04 M Na 2 HPO 4 containing 0.1% triethylamine (pHϭ5.65), immediately after HPLC purification. At predesignated time points, the rats were sacrificed by exsanguination under anesthesia. A sample (0.3-2.0 ml) of blood was collected at the time of euthanasia. Samples of the tissues were excised immediately and weighed. The tissue radioactivity was measured in a gamma counter (ALOKA, ARC-370) and the tissue radioactivity levels were expressed as percentages of injected dose per gram of tissue (%ID/g of tissue). In another set of experiments, each rat received 0.3 mg of sulfinpyrazone (100 ml, dissolved in 2.0% ethanol-saline containing 5% Tween 80) via intravenous injection 3 min prior to the radiotracer injection. The control group received only a solution of 2.0% ethanol-saline containing 5% Tween 80. The animals were sacrificed 10 min after the tracer injection (111 kBq, 150 ml), and tissue samples of sulfinpyrazone-pretreated and control rats were assayed for radioactivity as described above.
Whole-Body Autoradiography A ten-week-old female Sprague-Dawley rat weighing ca. 190 g was euthanized with an overdose of ether 60 min after a tail vein injection of a buffered solution of 6-131 IAsA (296 kBq). The hair was rapidly clipped, and the nasal cavity and anus were filled with a 5% aqueous solution of carboxymethylcellulose sodium salt. The carcass was frozen in a dry ice-hexane mixture. An approximately 40 mm-thick sagittal section was sliced and collected onto adhesive tape (MAG TAPE NA-70, Nakagawa Chemical, Japan) and freeze-dried. The contents of the stomach and intestines were not removed. The frozen section was covered with a protective membrane and then placed in a cassette against Fuji Phosphor Imaging Plates (cat. No. BAS-SR 2040). The plates were allowed to develop for 72 h at room temperature in a lead-shielded box. After completing exposure, the images were analyzed using a Bio-Image Analysis System (BAS 2500, Fuji Film Co., Ltd., Tokyo, Japan).
Tissue Distribution Studies in Hypolipidemic Rats Ten-week-old female Sprague-Dawley rats weighing ca. 190 g were pretreated with 4-aminopyrazolo [3,4-d] pyrimidine (4-APP) to induce hypolipidemia through the depletion of circulating cholesterol, according to the procedure described by Jonson and Welch. 35) 4-APP was dissolved in 10 mM sodium phosphate buffer (30 mg/ml, pHϭ3.3) and administered intraperitoneally (i.p.) for 3 d at a dose of 15 mg/kg per day. A subcutaneously (s.c.) injected physiological saline (3 ml) was administered in conjunction with the 4-APP injection to minimize hypovolemia. The corresponding control rats received an i.p. injection of the phosphate buffer and a subcutaneous injection of saline (3 ml) for 3 d. A buffered solution of 6-131 IAsA (925 kBq) was injected into the control and 4-APP treated rats. The radioactivity in tissues excised from each animal was measured 30 min after i.v. injection and the results were expressed as %ID/g. Tissue Distribution Studies in Nude Mice Bearing Adrenal-Derived Tumors Y-1 cells and PC12 cells were obtained from ATCC (Manassas, U.S.A.). The two groups of tumor models were generated by s.c. injection of Y-1 cells (5.0ϫ10 6 cells) and PC12 cells (2.0ϫ10 6 cells), respectively, into the flanks of 12-13-week old male nude mice (Crij: CD1-Foxn1 nu mice, Charles River Japan) by means of a Hamilton syringe. These cells were injected in a 1 : 1 volume ratio with a reconstituted basement membrane (Matrigel; Becton Dickinson and Company, U.S.A.). When the tumor diameter reached about 1 cm at 2-4 weeks after inoculation (tumor weight of at least 100 mg), Y-1 cells or PC12 cells were injected in tumor-bearing mice intravenously with a buffered solution of 6-131 IAsA (370 kBq). At predetermined times, the mice were sacrificed by exsanguinations; the blood was collected, the organs were excited, and weighed. The complete tumor was removed and separated from the muscle and skin. The distribution of radioactivity in the samples from each animal was measured with an Aloka auto-gamma scintillation counter and the results were expressed as %ID/g. Statistical Analysis Quantitative data were expressed as meanϮS.D. Means were compared using Student's t-test and p values Ͻ0.05 were considered statistically significant. Table 1 shows the results of the tissue distribution study carried out with 6-131 IAsA in female Sprague-Dawley rats. The adrenal glands showed the highest uptake of radioactivity (13.94Ϯ2.01%ID/g at 60 min) followed by the thyroid, lungs, ovaries, spleen and small intestine. The liver and kid- neys, being the organs adjacent to the adrenals, showed low uptake and the adrenal-to-tissue ratios reached values of 11.3 in the liver and 7.4 in the kidney 60 min after injection. Although the rat thyroid showed a progressive increase in tissue radioactivity with time, the uptake was lower (2.9% and 5.1% of the injected dose at 30 and 60 min postinjection, respectively) than that previously observed with mice. 34) Distribution was also assessed by whole-body autoradiography following injection of 6-131 IAsA in a female rat. One hour after injection, radioactivity preferentially accumulated in the adrenal, as shown in Fig. 2 . At this time, a clear accumulation of radioactivity was seen in the pyloric part of the stomach and the small intestine, and modest accumulation of radioactivity was also evident in the kidney, lung and liver. The image also showed a marked absence of radioactivity in the brain. In the autoradiographic studies of 14 C-AsA by Hammarstrom, 10) small differences were found in a time-dependent accumulation of radioactivity between the cortex and medulla of the adrenal. Although no effort was made to separate the adrenal cortex from medulla radioactivity in this study, the distribution of radioactivity throughout the adrenals seemed to be almost uniform. The present results with rats show that 6-131 IAsA exhibits favorable imaging characteristics to a high degree of rapid adrenal uptake, with moderate target-to-nontarget contrast, thus confirming our previous findings in mice. 34) Sulfinpyrazone is a uricosuric medication used to treat gout and has been used as a blocker of ascorbate transport in some cell types in vitro, 15, 36, 37) although its in vivo use has not been reported. We tested the in vivo effect of this inhibitor on the adrenal uptake of 6-131 IAsA. Sulfinpyrazone was almost insoluble in a buffered solution or saline alone due to its high lipophilicity, and intravenous administration of a single 1 mg/animal dose was found to cause serious bleeding in rats, which was an obstacle to carrying out a coinjection blocking study. Therefore, a 2.0% ethanol saline containing 5% Tween 80 was used to as cosolvents for preinjection use. As shown in Table 2 , pretreatment with sulfinpyrazone (0.3 mg/animal) caused a statistically significant decrease in radioactivity in the uptake of adrenal glands com- pared with the control group, although the blocking effect was moderate. Organs such as the spleen and kidneys also showed lower uptake in the blocking study. 6-IAsA is closely similar to AsA in its cellular mechanism of transport in vitro, 32, 33) and in its antioxidant activity. 38) In the present study, it is important to note that pretreatment with sulfinpyrazone inhibited adrenal uptake of 6-131 IAsA in vivo, thus seemingly illustrating the participation of the SVCT transporter (probably the SVCT-2 subtype) in the distribution of 6-131 IAsA to the tissues. 4-Aminopyrazolo[3,4-d]pyrimidine (4-APP) is known to produce hypolipidemia by the inhibition of lipoprotein biosynthesis. 39) Administration of 4-APP to rats has been reported to induce a marked depletion of cholesterol from the adrenal glands, upregulation of low-density lipoprotein receptors on adrenal cell membranes, [40] [41] [42] and high plasma adrenocorticotropic hormone (ACTH) levels. 43, 44) The rat adrenal uptake of potential adrenal imaging agents such as radioiodinated cholesteryl esters 42, 45) and cholesteryl-p-[ 18 F]fluorobenzoate, 35) has been shown to increase when pretreated with 4-APP. Although the function of AsA in the adrenal gland is incompletely understood, the participation of AsA in steroidogenesis has been suggested for a long time. In addition, Mohammadzadeh et al. 13) and Mishkin and Castronovo 46) observed that 14 C-AsA uptake by the adrenal glands of dogs or guinea pigs was significantly increased when ACTH was injected one hour before the tracer was administered. In contrast with these results, it has also been reported that the inhibition of AsA transport or uptake by the adrenal glands occurs due to corticoids produced in response to ACTH. 47) Thus, we carried out a similar experiment to see the response to 4-APP-treatment for 6-131 IAsA. Our studies with 4-APP-treated rats (15 mg/kg i.p., once daily for 3 d) 30 min after injection showed a 1.7-fold greater uptake of radioactivity in the adrenals in comparison with the control, as shown in Table 3 . There was also a slight increase in radioactivity concentration in the small intestine, spleen and ovaries, while no significant changes were observed in the blood clearance and remaining tissues. The observed response of adrenal uptake for 6-131 IAsA appears to be not as great when compared with that for cholesteryl-p-[ 18 F]fluorobenzoate using the same 4-APP-treated rats. 35) This finding indicates that IAsA is a radiotracer with in vivo sensitivity to the disorders of adrenal glands induced by 4-APP. Further studies, however, are necessary to clarify its enhancement mechanism, although repeated administration of 4-APP may induce up-regulation of the ascorbate transporter expression.
RESULTS AND DISCUSSION
We are also interested in exploring radiolabeled AsA analogs suitable for potential use as brain imaging agents, because AsA is highly concentrated in the brain, with the important function of maintaining brain homeostasis as a neuromodulator and antioxidant. 48) It has been reported that ascorbate enters the CSF either directly through the choroid plexus via the SVCT-2, or as dehydroascorbic acid (DHA) through the GLUT transporters across the blood-brainbarrier. 32, 48, 49) In the present study we confirmed the limited transfer of 6-131 IAsA in the rat brain, as observed in mouse brain, 34) indicating the unsuitability of this agent for brain studies in vivo. These observations are consistent with the mechanistic hypothesis of Rumsey et al. 33) and Corpe et al. 50) that ascorbate analogs modified at C-6, such as 6-131 IAsA, can not form the stable bicyclic hemiketal structure in solution necessary for transport through the GLUT-type glucose transporter, in contrast to DHA, thus preventing its uptake by the GLUT transporters.
Diagnostic evaluation of clinically suspected adrenal tumors consists mainly of lesion detection and precise anatomic localization. 51, 52) For example, labeled radioiodinated 6-beta-iodomethylnorcholesterol scintigraphy is used for detecting adrenocortical tumor tissues. 11 C-Labeled analog of metomidate represents a PET agent that can be used to distinguish adrenocortical tumors from metastatic cancer based on targeting specific enzymes expressed in adrenocortical tumors. In addition, adrenal imaging agents, such as radioiodinated meta-iodobenzylguanidine and 11 C-labeled hydroxyephedrine, are mainly used for medullary chromaffin tissue lesions, and 2-deoxy-2-[ 18 F]fluoro-D-glucose is proposed for diagnosing, staging and detecting recurrences of adrenal maligno masses.
There is a lot of literature on the use of high-dose vitamin C in cancer therapy, but no clear answer has yet been raised about its putative anticancer action. 53, 54) On the other hand, it has been demonstrated that accumulation of AsA in the tumor cells is mainly achieved through the dehydroascorbic acid (DHA) transport pathway, 55) which involves (i) extracellular oxidation of ascorbate to DHA, (ii) transport of DHA by the GLUT transporters, and (iii) intracellular reduction of DHA to ascorbate, thus explaining the poor penetration of AsA itself into tumor tissues. In fact, in our previous work with 6-131 IAsA using fibrosarcoma-bearing mice, the tumor tissues showed a low accumulation of radioactivity with a low tumor-to-blood ratio. 34) It is well known that cancer cells occasionally express the phenotype of their original tissues and organs, and if tumors originating from adrenal glands possess an ascorbate transporter with a substrate specificity similar to that in adrenal glands, we thought that radioiodinated 6-IAsA might be a useful agent to help either diagnosis or as a means of targeting radiotherapy for adrenal tumors. For this purpose, we examined the potential of tumor imaging of 6-131 IAsA in female nude mice implanted with either Y-1 adrenocortical tumor cells or adrenal medulla-derived PC12 cells. Mouse Y-1 adrenocortical tumor cells, producing an excess of cortisol, aldosterone or sex-steroids, retain responsiveness to ACTH. 56) PC12 cells are rat tumor cells, arising from chromaffin cells in the adrenal medulla and expressing neuronal catecholamine transporters. 57) As shown in Tables 4 and 5, in both tumor models, 6-131 IAsAs displayed rapid blood clearance; 1.23Ϯ0.59 and 0.63Ϯ0.01% ID/g blood uptake was observed 60 min after injection, for Y-1 cells and PC12 tumor-bearing mice, respectively. The tumor uptake values were 8.98Ϯ4.69 and 3.71Ϯ0.34% ID/g in Y-1 cells and PC12 60 min after injection, respectively. For both tumor models, the highest uptake occurred in the normal adrenal gland followed by the lungs and thyroid at all time points of the study, similar to that in normal mice. Contrary to our expectations, the radioactivity in both tumor tissues was quite low, with 20-30% of that in the normal adrenal gland and the tumor-to-normal tissue ratios were low, although they gradually increased with time. The radioactivity uptake in normal adrenal glands reached a maximum at 10 min post injection and then continuously de-creased up to 60 min, whereas the tumor tissues showed a consecutively slight increase during the 60-min period, thus proving very different accumulation behavior. These results suggest that 6-131 IAsA is not a suitable radiotracer for characterizing adrenal-derived tumors, based on ascorbate bioactivity. Although the explanation for this is not clear, it may simply reflect that these tumor tissues used in our study have no or only low transport capacity (possibly SVCT-2) for IAsA, but further studies are needed to confirm this finding.
Attempts to identify the accumulated radioactivity in the adrenals and blood of rats failed to find optimal conditions for analysis: TLC analysis was considerably complex, being accompanied by the formation of free [ 131 I]iodide and radioactive species probably formed in the attempted tissue extraction step and chromatographic separation due to the labile nature of 6-131 IAsA. In our previous studies and this work there was a continuously increasing accumulation of radioactivity in the adrenal glands during a 30-to 60-min interval. As described previously, 34) the presence of a carrier molecule as well as a labeling precursor, 6-bromo-6-deoxy-Lascorbic acid in the injection, or endogenous molecules in the body might have contributed partially as antioxidants to the in vivo stability of 6-131 IAsA.
CONCLUSION
A survey of literature reveals that, while the two enols at the C-2 and C-3 positions of AsA play a crucial role in eliciting biological response, the hydroxyl group at the C-6 position is relatively unimportant in the function of the vitamin. 33, 50) 6-IAsA is an analog of AsA in which an iodine atom replaces a hydroxyl group at the C-6 position of AsA, and studies on the transport mechanism have demonstrated that the accumulation of 6-IAsA and AsA is very similar in cells in which the ascorbate transporter pathway is expected to dominate. 32, 33) We recently synthesized 6-131 IAsA and preliminarily evaluated its biodistribution in mice. In the present study, whole-body autoradiographic distribution of 6-131 IAsA in rats is very similar to that obtained by dissection studies, in which very intense uptake was again identified in the adrenal gland, an organ that is known to highly express the SVCT-2 transporter. Adrenal uptake of 6-131 IAsA in vivo appears to be SVCT-mediated since preinjection of sulfinpyrazone, a known blocker of ascorbate transport, eliminated adrenal uptake. The 4-APP-treated rats responded to specific increased adrenal uptake of 6-131 IAsA. The results obtained with two adrenal-derived tumor models for 6-131 IAsA demonstrated poor targeting of radioactivity in both tumor tissues, although while showing preferential distribution of radioactivity from the blood into the tumor tissues. Radioiodinated 6-IAsA is not suitable as a positive imaging for adrenal tumor tissues, but might have potential application as a negative imaging probe for evaluating the malignancy of adrenocortical tumors, based on decreased accumulation of this agent in adrenocortical tumors than in normal tissues.
In a previous work we found that 6-131 IAsA has limited stability in solution, therefore requiring the use of a nitrogendegassed HPLC solvent in the purification step and storage at near 0°C in order to avoid exposure to an oxidative environment. 34) In this study there was often a relatively large varia- tion in the radiochemical purity among different preparations. This disadvantage of susceptibility to thermal and oxidation degradation during preparation and storage, in addition to in vivo deiodination, may represent an obstacle to practical application of this agent. Further structural modifications may lead to more favorable probes for in vivo tumorand cerebral-targeting.
